ADULT GYNECOLOGICAL TUMORS

Clinical trials for ADULT GYNECOLOGICAL TUMORS explained in plain language.

Never miss a new study

Get alerted when new ADULT GYNECOLOGICAL TUMORS trials appear

Sign up with your email to follow new studies for ADULT GYNECOLOGICAL TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Experimental immune cell therapy tested in one patient with advanced gynecological cancer

Disease control Terminated

This early-phase study tested an experimental therapy called GT201, made from a patient's own immune cells (tumor-infiltrating lymphocytes), for advanced gynecological tumors. Only one participant was enrolled before the study was terminated. The goal was to check safety and see …

Matched conditions: ADULT GYNECOLOGICAL TUMORS

Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control

Last updated May 07, 2026 18:39 UTC

ADULT GYNECOLOGICAL TUMORS

Get alerted when new ADULT GYNECOLOGICAL TUMORS trials appear

Experimental immune cell therapy tested in one patient with advanced gynecological cancer